Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Leidos awarded CDC's National Health Safety Network modernization contract
-
Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extend
-
Vasa Therapeutics Announces Initiation of Phase 1 First-in-Human Clinical Trial of VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction
-
Rectify Pharmaceuticals Appoints Pol Boudes as Chief Medical Officer
-
Enviri Corporation to participate in upcoming investor conferences
-
NexTech Solutions (NTS) Acquires Virginia-Based IT Company Nomad Solutions, Expanding Support to Federal Civilian Executive Agencies
-
PANTHERx® Rare Selected by Calliditas Therapeutics as Specialty Pharmacy for TARPEYO®
-
The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference
-
University of Mississippi Medical Center Launches Student Loan Benefit with Fiducius to Support Employee Recruiting and Retentions Efforts
-
Pole Star Global Expands Maritime Intelligence with Launch of the DOMAIN Insights Engine Plus New Global Brand
-
LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
Maxeon Solar Technologies Announces Second Quarter 2024 Financial Results
-
FIT KING's Award-Winning Innovation: The Recovery Pro Full Leg Compression Massage Boots
-
First Federal Savings Bank and ICBA: Take Steps to Safeguard Your Finances During National Preparedness Month
-
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
-
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
-
Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions
-
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
Easterly Government Properties Completes Acquisition of VA - Jacksonville, the Final Acquisition of the 10 Properties in the VA Portfolio
-
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Hedge Fund Association Announces Results of 2024 Global Board of Directors Election
-
Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
-
Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for Zorevunersen to be the First Disease-Modifying Medicine for the Treatment of Dravet
-
ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)
-
Golden State Wealth Management Welcomes New Advisor, Valerie Krebs
-
SENKO AND US CONEC SETTLE VSFF CONNECTOR AND ADAPTER PATENT DISPUTES
-
Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis
-
Applebee’s® Kicks Off the 2024 NFL Season with America’s Favorite Boneless Wings for Only 50 Cents
-
IntegriChain Appoints Tim Murdoch as Chief Commercial Officer to Drive Continued Growth and Customer Value
-
Calamos Announces Launch and Upside Cap Rates for CPST and CPNS: Structured Protection ETFs Providing Exposure to S&P 500 and Nasdaq-100 with 100% Downside Protection Over One Year
-
The US Oncology Network Extends its Reach in Illinois as Illinois CancerCare Joins The Network
-
Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer
-
ConocoPhillips appoints Nelda J. Connors to its board of directors
-
RTI to Exhibit at AFA’s Air, Space and Cyber Conference 2024
-
Redbrick Secures U.S. Patent for "Open Metaverse Creation System"
-
Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
-
Cambridge Associates Expands Alternative Investment Services with Acquisition of SIGLO Capital Advisors
-
Altium 365 Apps Now Available in AWS Marketplace for Collaborative, Secure Design of Electronics Hardware
-
LandGate joins Esri's Partner Network to Provide Crucial Geospatial Data Solutions for Renewable Energy, Data Centers, and Commercial Development
-
Compass Therapeutics to Participate in Upcoming Investor Events
-
Small Business Owners to ABC News: Make Small Business Issues a Topic of Presidential Debate
-
Report: Women Increasingly Serving as “CFO” of Their Households, yet Uncertain About Achieving Financial Goals
-
Moe's Southwest Grill® and Cheez-It® Bring on the Cheesy Crunch
-
Bardstown Bourbon Co. Introduces Silver Oak Finish, Discovery 12 in Time for Bourbon Heritage Month
-
Molinare Tames Workflow Complexity With Ngenea® Software From pixitmedia, a Kalray Company
-
AAON Launches Delta Class, The Next Evolution in DOAS Technology
-
Wells Fargo to Present at the Barclays Global Financial Services Conference
-
Element Six wins U.S. Department of Defense UWBGS program
-
T2S Solutions Acquires Flexitech Aerospace, Expanding Its Footprint into Spaceflight Product Offerings for Earth Orbit and Lunar Operations
